Sunesis Pharmaceuticals, Inc. Earnings Conference Call (Q2 2012) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Aug 9 Calls
Today's Calls
Call Details
Sunesis Pharmaceuticals, Inc. Earnings Conference Call (Q2 2012)
Scheduled to start Thu, Aug 9, 2012, 10:30 am Eastern

Check back at the scheduled start time for
the audio link to appear in this spot.

Add this event to your Yahoo! Calendar Add This Event To Your Yahoo! Calendar

About Sunesis Pharmaceuticals Inc (NasdaqCM:SNSS)
Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. Its lead product candidate is Voreloxin, an anticancer quinolone derivative (AQD) for the treatment of cancer. The company is conducting various clinical trials of Voreloxin, including a Phase 2 clinical trial, known as the REVEAL-1 trial, in previously untreated elderly patients with acute myeloid leukemia (AML); a Phase 1b/2 clinical trial combining Voreloxin with cytarabine for the treatment of patients with relapsed/refractory AML; and a Phase 2 single agent clinical trial in platinum-resistant ovarian cancer patients. It has a license agreement with Dainippon Sumitomo Pharma Co., Ltd. for the development and marketing of Voreloxin; and a collaboration agreement with Biogen Idec, Inc. to discover, develop, and commercialize small molecule inhibitors of Raf kinase and up to five additional targets that play a role in oncology and immunology indications. The company, formerly known as Mosaic Pharmaceuticals, Inc., was founded in 1998 and is headquartered in South San Francisco, California.

More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings

Copyright © 2012 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2012 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.